Belgium vs Republic of Moldova: Protecting minority investors: Strength of minority investor
Belgium
34 DB15-20 methodology
in 2019
Republic of Moldova
34 DB15-20 methodology
in 2019
Belgium rank
45th
Republic of Moldova rank
45th
Protecting minority investors: Strength of minority investor over time
- Belgium
- Republic of Moldova
How they compare
Belgium currently reports 34 DB15-20 methodology against 34 DB15-20 methodology in Republic of Moldova, a difference of 0 DB15-20 methodology.
Across all 7 years both countries report, Republic of Moldova has been ahead every year.
Belgium ranks 45th and Republic of Moldova ranks 45th of 191 countries.
Frequently asked questions
- Which has higher protecting minority investors: strength of minority investor, Belgium or Republic of Moldova?
- Belgium, at 34 DB15-20 methodology against 34 DB15-20 methodology in Republic of Moldova as of 2019.
- What is the difference in protecting minority investors: strength of minority investor between Belgium and Republic of Moldova?
- 0 DB15-20 methodology, with Belgium ahead.
- How many years of comparable data are there for Belgium and Republic of Moldova?
- 7 years are reported by both, from 2013 to 2019.
- How do Belgium and Republic of Moldova rank globally for protecting minority investors: strength of minority investor?
- Belgium ranks 45th and Republic of Moldova ranks 45th of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Strength of minority investor protection index (0-50) (DB15-20 methodology). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The strength of minority investor protection index is the sum of the extent of disclosure index, extent of director liability index, ease of shareholder suits index, extent of shareholder rights index, extent of ownership and control index and extent of corporate transparency index. The index is computed based on the methodology in the DB15-20 studies.